ASRS
GLUE icon

Arizona State Retirement System’s Monte Rosa Therapeutics GLUE Stock Holding History

Arizona State Retirement System’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,951
Closed -$57.2K – 2169
2023
Q3 		$57.2K Buy
11,951
+166
+1% +$1.07K ﹤0.01% 2139
2023
Q2 		$80.7K Buy
+11,785
New +$76.2K ﹤0.01% 2144

Other funds holding GLUE

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Arizona State Retirement System's GLUE Position: Q4 2023 in Review

Arizona State Retirement System sold out of Monte Rosa Therapeutics (GLUE) in Q4 2023, closing a stake of 11,951 shares — an estimated $57.2K sold.

Arizona State Retirement System first reported a position in GLUE in Q2 2023 and held it in 2 quarters. The position peaked at $80.7K in Q2 2023. 71 funds tracked by Wall St. Rank hold GLUE as of Q4 2023.

  • Arizona State Retirement System reported no remaining Monte Rosa Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Arizona State Retirement System sold 11,951 Monte Rosa Therapeutics shares in Q4 2023, an estimated $57.2K.
  • Arizona State Retirement System first reported a position in Monte Rosa Therapeutics in Q2 2023 and held it in 2 quarters.
  • Arizona State Retirement System's Monte Rosa Therapeutics position peaked at $80.7K in Q2 2023.
  • 71 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q4 2023.

Based on Arizona State Retirement System's 13F filing for Q4 2023, filed 24 Jan 2024.